Goldman Sachs Group Inc Ishares Biotechnology ETF Call Options Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

Call Options

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2023 May 14, 2024	BUY	$121.97 - $137.23 $1.74 Million - $1.96 Million	14,300 Added 250.88%	20,000 $2.58 Million
Q1 2023 May 11, 2023	BUY	$121.97 - $137.23 $2.44 Million - $2.74 Million	20,000 New	20,000 $2.58 Million
Q2 2022 May 14, 2024	SELL	$105.82 - $134.76 $1.51 Million - $1.93 Million	-14,300 Reduced 71.5%	5,700 $670,000
Q2 2022 Aug 15, 2022	SELL	$105.82 - $134.76 $1.9 Million - $2.43 Million	-18,000 Reduced 75.95%	5,700 $670,000
Q4 2021 Feb 14, 2022	BUY	$145.27 - $164.78 $1.28 Million - $1.45 Million	8,800 Added 59.06%	23,700 $3.62 Million
Q3 2021 Nov 10, 2021	BUY	$158.89 - $176.21 $2.37 Million - $2.63 Million	14,900 New	14,900 $2.41 Million

Others Institutions Holding IBB

# of Institutions

939

Shares Held

31.3M

Call Options Held

4.82M

Put Options Held

5.95M

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.